相似文献
1
Biotech's wellspring: the health of private biotech in 2013.
Nat Biotechnol. 2014 May;32(5):428-35. doi: 10.1038/nbt.2905.
2
Biotech's wellspring: the health of private biotech in 2012.
Nat Biotechnol. 2013 May;31(5):396-403. doi: 10.1038/nbt.2577.
3
Biotech's wellspring-a survey of the health of the private sector in 2016.
Nat Biotechnol. 2017 May 9;35(5):413-420. doi: 10.1038/nbt.3867.
4
Biotech's wellspring-a survey of the health of the private sector in 2015.
Nat Biotechnol. 2016 Jun 9;34(6):608-15. doi: 10.1038/nbt.3600.
5
Biotech's wellspring: a survey of the health of the private sector.
Nat Biotechnol. 2012 May 7;30(5):395-400. doi: 10.1038/nbt.2209.
6
Biotech's wellspring--a survey of the health of the private sector in 2014.
Nat Biotechnol. 2015 May;33(5):470-7. doi: 10.1038/nbt.3218.
7
The role of the private sector in biotechnology: research and development.
Health Matrix Clevel. 2002 Summer;12(2):357-65.
8
Biotech's uncertain present.
Lancet. 1996 Jun 1;347(9014):1497.
9
Private biotech 2004--the numbers.
Nat Biotechnol. 2006 Jun;24(6):635-41. doi: 10.1038/nbt0606-635.
10
A lifeline for the biotech sector.
Nat Biotechnol. 2009 Feb;27(2):123-4. doi: 10.1038/nbt0209-123.
引用本文的文献
1
The service-based bioeconomy.
Nat Biotechnol. 2014 Jul;32(7):597. doi: 10.1038/nbt.2961.
本文引用的文献
1
Burning bright.
Nat Biotechnol. 2013 Dec;31(12):1068-71. doi: 10.1038/nbt.2766.
2
Sequestration to slash research grants and delay biosimilars.
Nat Biotechnol. 2013 Apr;31(4):271. doi: 10.1038/nbt0413-271.
Zotero 插件